Christy Cheruvil, Pharm.D

Education

  • Residency, PGY-2 Ambulatory Pharmacy, ASHP Accredited, State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences
  • Residency, PGY-1, Pharmacy, ASHP Accredited, State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences
  • Doctor of Pharmacy, State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences, Scholars Program Micro-credential

Honors/Awards

  • Rho Chi Honor Society
  • School of Pharmacy and Pharmaceutical Sciences Certificate of Recognition

Publications/Presentations

  • Wojakowski E, Cheruvil C, Hassan A, Holsen MR, Chen L, Rossi M, Wilcox N, Woodruff A, “Albumin and bleed risk in rivaroxaban treated patients”, Manuscript accepted, Buffalo General Medical Center. Buffalo, NY. April 2020
  • Cheruvil C, Miller C, Feldman E, Darko W, Probst L, Seabury R, “Comparison of fixed 5 units dose of intravenous regular insulin versus weight-based 0.1 units/kg for the treatment of hyperkalemia”, Manuscript in process, Upstate University Hospital Syracuse, NY. December 2019
  • Cheruvil C, Miller C, Feldman E, Darko W, Probst L, Seabury R, “Evaluation of 4 Factor Prothrombin Complex Concentrate for Coagulopathy Related to Liver Dysfunction”, Poster Presentation - Vizient Annual Pharmacy Conference. Las Vegas, NV. December 2019
  • Cheruvil C, Woodruff A, Wojakowski E, “Hypoalbuminemia and risk of bleeding in patients treated with rivaroxaban”, Poster Presentation - ASHP Midyear Anaheim, CA. December 2018

find a provider doctorIcon-white.png